MYO5B and cholestasis: MYO5B mutations have been associated with microvillus inclusion body disease (MVID), which affects the targeting of the tubule membrane by BSEP and leads to impaired bile acid excretion, ultimately causing cholestasis (Qiu et al., 2017).